These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Partially Treated Catatonia and Incipient Neuroleptic Malignant Syndrome: A Challenging Presentation. Mahgoub Y; Uy R; Hartman J Prim Care Companion CNS Disord; 2020 Oct; 22(5):. PubMed ID: 33031648 [No Abstract] [Full Text] [Related]
31. Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report. Angulo NY; Castaño PA; Gómez CC; Quintero S Biomedica; 2022 Sep; 42(3):445-449. PubMed ID: 36122284 [TBL] [Abstract][Full Text] [Related]
32. Lithium-induced fatal neuroleptic malignant syndrome in a patient not being concomitantly treated with commonly offending agents. Argyriou AA; Drakoulogona O; Karanasios P; Kouliasa L; Leonidou L; Giannakopoulou F; Goudas P; Makris N J Pain Symptom Manage; 2012 Dec; 44(6):e4-6. PubMed ID: 23217454 [No Abstract] [Full Text] [Related]
33. Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome. Brantley E; Cohn J; Babu K J Med Toxicol; 2009 Jun; 5(2):92-8. PubMed ID: 19415596 [No Abstract] [Full Text] [Related]
34. An agitated young man. Mann F; Sobel A BMJ; 2010 Mar; 340():c732. PubMed ID: 20356963 [No Abstract] [Full Text] [Related]
35. Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment. Oglodek E; Szota A; Araszkiewicz A Aust N Z J Psychiatry; 2013 Oct; 47(10):972. PubMed ID: 23630396 [No Abstract] [Full Text] [Related]
36. Recognition, assessment and management of neuroleptic malignant syndrome. Khan M; Farver D S D J Med; 2000 Sep; 53(9):395-400. PubMed ID: 11016275 [TBL] [Abstract][Full Text] [Related]
37. Neuroleptic malignant syndrome and its controversies. Margetić B; Aukst-Margetić B Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454 [TBL] [Abstract][Full Text] [Related]